Kroger (KR) is a publicly traded Consumer Defensive sector company. As of November 15, 2026, KR trades at $70.80 with a market cap of $41.81B and a P/E ratio of 32.09. KR moved +2.02% today. Year to date, KR is +14.58%; over the trailing twelve months it is +7.32%. Its 52-week range spans $54.15 to $76.58. Analyst consensus is buy with an average price target of $69.56. Rallies surfaces KR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alaska high court revives opioid lawsuit against pharmacy operators: Alaska’s Supreme Court ruled the state can pursue a public nuisance claim alleging Albertsons and Kroger pharmacies failed to meet obligations when dispensing opioids. The state is seeking remedies that could include addiction treatment and wider naloxone availability if the companies are found liable.
| Metric | Value |
|---|---|
| Price | $70.80 |
| Market Cap | $41.81B |
| P/E Ratio | 32.09 |
| EPS | $1.82 |
| Dividend Yield | 0.39% |
| 52-Week High | $76.58 |
| 52-Week Low | $54.15 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $149.33B |
| Net Income | $1.09B |
| Gross Margin | 0.00% |
19 analysts cover KR: 0 strong buy, 11 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $69.56.